wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28078423-AA481A3F-6DB5-4F5F-97BF-20AA6A97344B
Q28078423-AA481A3F-6DB5-4F5F-97BF-20AA6A97344B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28078423-AA481A3F-6DB5-4F5F-97BF-20AA6A97344B
Monoclonal Antibody and Fusion Protein Biosimilars Across Therapeutic Areas: A Systematic Review of Published Evidence
P2860
Q28078423-AA481A3F-6DB5-4F5F-97BF-20AA6A97344B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28078423-AA481A3F-6DB5-4F5F-97BF-20AA6A97344B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d9e20211ffebeda7a5d1adf9632314610d99c256
P2860
A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy.